Relation of myocardial T2*to right ventricular function in thalassaemia major

被引:35
作者
Alpendurada, Francisco [1 ]
Carpenter, John-Paul [1 ,3 ]
Deac, Monica [1 ]
Kirk, Paul [1 ,3 ]
Walker, J. Malcolm [2 ]
Porter, John B. [2 ]
Banya, Winston [1 ,3 ]
He, Taigang [1 ,3 ]
Smith, Gill C. [1 ,3 ]
Pennell, Dudley J. [1 ,3 ]
机构
[1] Royal Brompton Hosp, Cardiovasc Magnet Resonance Unit, London SW3 6NP, England
[2] UCL, London, England
[3] Univ London Imperial Coll Sci Technol & Med, London, England
关键词
Iron overload; Right ventricle; Heart failure; T2-ASTERISK-CARDIOVASCULAR MAGNETIC-RESONANCE; PULMONARY-HYPERTENSION; DIASTOLIC FUNCTION; EJECTION FRACTION; INTERSTUDY REPRODUCIBILITY; ORAL DEFERIPRONE; GREAT-ARTERIES; IRON; SURVIVAL; CARDIOMYOPATHY;
D O I
10.1093/eurheartj/ehq106
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Myocardial T2* cardiovascular magnetic resonance (CMR) provides a rapid and reproducible measure of cardiac iron loading and is being increasingly used worldwide for monitoring of transfusion-dependent thalassaemia patients. Although myocardial siderosis (T2* < 20 ms) is associated with impaired left ventricular (LV) function, little is known of its relation with right ventricular (RV) function. The aim of this study was to investigate the relationship between cardiac T2* and RV function. A retrospective analysis of 319 patients with beta-thalassaemia major presenting for their first CMR scan was performed (45.1% male, mean age 25.6 years). In patients with normal myocardial T2* (> 20 ms), the RV ejection fraction (EF) was within the normal range in 98% of patients. When myocardial T2* was < 20 ms, there was a progressive and significant decline in RV EF. There was a linear relationship between RV and LV EF. Myocardial iron deposition is strongly associated with RV dysfunction, which mirrors the decrease in LV function seen with worsening cardiac iron loading. Right ventricular dysfunction may play a significant role in heart failure associated with myocardial siderosis.
引用
收藏
页码:1648 / 1654
页数:7
相关论文
共 43 条
[1]
Cardiac status in well-treated patients with thalassemia major [J].
Aessopos, A ;
Farmakis, D ;
Hatziliami, A ;
Fragodimitri, C ;
Karabatsos, F ;
Joussef, J ;
Mitilineou, E ;
Diamanti-Kandaraki, E ;
Meletis, J ;
Karagiorga, M .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 73 (05) :359-366
[2]
Pulmonary hypertension in β-thalassemia. [J].
Aessopos, A ;
Farmakis, D .
COOLEY'S ANEMIA EIGHTH SYMPOSIUM, 2005, 1054 :342-349
[3]
Thalassernia heart disease - A comparative evaluation of Thalassemia major and Thalassemia intermedia [J].
Aessopos, A ;
Farmakis, D ;
Deftereos, S ;
Tsironi, A ;
Tassiopoulos, S ;
Moyssakis, I ;
Karagiorga, M .
CHEST, 2005, 127 (05) :1523-1530
[4]
Cardiac involvement in thalassemia intermedia: a multicenter study [J].
Aessopos, A ;
Farmakis, D ;
Karagiorga, M ;
Voskaridou, E ;
Loutradi, A ;
Hatziliami, A ;
Joussef, J ;
Rombos, J ;
Loukopoulos, D .
BLOOD, 2001, 97 (11) :3411-3416
[5]
Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia [J].
Anderson, LJ ;
Wonke, B ;
Prescott, E ;
Holden, S ;
Walker, JM ;
Pennell, DJ .
LANCET, 2002, 360 (9332) :516-520
[6]
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload [J].
Anderson, LJ ;
Holden, S ;
Davis, B ;
Prescott, E ;
Charrier, CC ;
Bunce, NH ;
Firmin, DN ;
Wonke, B ;
Porter, J ;
Walker, JM ;
Pennell, DJ .
EUROPEAN HEART JOURNAL, 2001, 22 (23) :2171-2179
[7]
Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2*cardiovascular magnetic resonance [J].
Anderson, LJ ;
Westwood, MA ;
Holden, S ;
Davis, B ;
Prescott, E ;
Wonke, B ;
Porter, JB ;
Walker, JM ;
Pennell, DJ .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 127 (03) :348-355
[8]
Borgna-Pignatti C, 2004, HAEMATOLOGICA, V89, P1187
[9]
CARPENTER JP, 2009, J CARDIOVASC MAGN S1, V11, pP224
[10]
Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure [J].
de Groote, P ;
Millaire, A ;
Foucher-Hossein, C ;
Nugue, O ;
Marchandise, X ;
Ducloux, G ;
Lablanche, JM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (04) :948-954